Immunisation efficacy of a stabilised SARS-CoV-2 spike glycoprotein in two geriatric animal models
Description
Age is associated with reduced efficacy of vaccines and linked to higher risk of severe COVID-19. Here we determined the impact of ageing on the efficacy of a SARS-CoV-2 vaccine based on a stabilised Spike glycoprotein (S-29) that had previously
